These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645 [TBL] [Abstract][Full Text] [Related]
6. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Ekselius L; von Knorring L; Eberhard G Int Clin Psychopharmacol; 1997 Nov; 12(6):323-31. PubMed ID: 9547134 [TBL] [Abstract][Full Text] [Related]
7. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. Robinson RG; Jorge RE; Moser DJ; Acion L; Solodkin A; Small SL; Fonzetti P; Hegel M; Arndt S JAMA; 2008 May; 299(20):2391-400. PubMed ID: 18505948 [TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Wagner KD; Robb AS; Findling RL; Jin J; Gutierrez MM; Heydorn WE Am J Psychiatry; 2004 Jun; 161(6):1079-83. PubMed ID: 15169696 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial. Guelfi JD; Strub N; Loft H J Affect Disord; 2000 Jun; 58(3):201-9. PubMed ID: 10802128 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of resistant depression with the citalopram-lithium combination. Methodology of a double-blind multicenter study and preliminary results]. Souche A; Montaldi S; Uehlinger C; Kasas A; Reymond MJ; Reymond P; Baumann P; Dufour H Encephale; 1991; 17(3):213-9. PubMed ID: 1864255 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Kyle CJ; Petersen HE; Overø KF Depress Anxiety; 1998; 8(4):147-53. PubMed ID: 9871816 [TBL] [Abstract][Full Text] [Related]
12. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Kraus MR; Schäfer A; Schöttker K; Keicher C; Weissbrich B; Hofbauer I; Scheurlen M Gut; 2008 Apr; 57(4):531-6. PubMed ID: 18079286 [TBL] [Abstract][Full Text] [Related]
13. Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. Patris M; Bouchard JM; Bougerol T; Charbonnier JF; Chevalier JF; Clerc G; Cyran C; Van Amerongen P; Lemming O; Høpfner Petersen HE Int Clin Psychopharmacol; 1996 Jun; 11(2):129-36. PubMed ID: 8803650 [TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Mendels J; Kiev A; Fabre LF Depress Anxiety; 1999; 9(2):54-60. PubMed ID: 10207659 [TBL] [Abstract][Full Text] [Related]
15. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial. Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048 [TBL] [Abstract][Full Text] [Related]
16. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. Palomäki H; Kaste M; Berg A; Lönnqvist R; Lönnqvist J; Lehtihalmes M; Hares J J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):490-4. PubMed ID: 10201422 [TBL] [Abstract][Full Text] [Related]
17. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Nyth AL; Gottfries CG; Lyby K; Smedegaard-Andersen L; Gylding-Sabroe J; Kristensen M; Refsum HE; Ofsti E; Eriksson S; Syversen S Acta Psychiatr Scand; 1992 Aug; 86(2):138-45. PubMed ID: 1529737 [TBL] [Abstract][Full Text] [Related]
18. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826 [TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression. Alexopoulos GS; Canuso CM; Gharabawi GM; Bossie CA; Greenspan A; Turkoz I; Reynolds C Am J Geriatr Psychiatry; 2008 Jan; 16(1):21-30. PubMed ID: 17928573 [TBL] [Abstract][Full Text] [Related]
20. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China. Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]